GlucoTrack, Inc. (NASDAQ:GCTK – Get Rating) saw a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 6,000 shares, a growth of 9.1% from the September 30th total of 5,500 shares. Currently, 0.1% of the company's shares are short sold. Based on an average trading volume of 3,100 shares, the short-interest ratio is presently 1.9 days.
GlucoTrack Stock Up 0.5 %
GlucoTrack stock traded up $0.01 during mid-day trading on Tuesday, hitting $1.85. The company's stock had a trading volume of 164 shares, compared to its average volume of 7,210. GlucoTrack has a 1 year low of $1.56 and a 1 year high of $4.85. The company has a current ratio of 4.52, a quick ratio of 4.52 and a debt-to-equity ratio of 0.06. The stock's fifty day moving average is $1.94 and its two-hundred day moving average is $2.34.
Get GlucoTrack alerts:About GlucoTrack
(Get Rating)
GlucoTrack, Inc, a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.Read More
- Get a free copy of the StockNews.com research report on GlucoTrack (GCTK)
- Uber Stock Surge On The Back Of Profitabilty
- Online Lender SoFi Jumps 14% On Better-Than-Expected Q3 Results
- Why American Water Works May Not Want a Fed Pivot
- Strong Q3 Driving Growth At S&P 500 Component Citizens Financial
- The Institutions Are Comfortable With The Furniture Industry
Receive News & Ratings for GlucoTrack Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlucoTrack and related companies with MarketBeat.com's FREE daily email newsletter.